Delivery Order SPE2DB22D2206-SPE2DB25FJS65
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Fentanyl 100 micrograms per 2 milliliter vials at a ceiling value of $1,345.37. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion by December 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a...
- The Defense Logistics Agency awarded a delivery order valued at $1,309.28 to AmerisourceBergen Drug Corp for the supply of Fentanyl 100 mcg/2 mL vials on July 14, 2025, with an ultimate completion date of July 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to a qualified vendor. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,162.00 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Fentanyl 2,500 micrograms per 50 milliliter vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 28, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,365.40 to AmerisourceBergen Drug Corp for Fentanyl 100 mcg/2 mL vials on July 28, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order is scheduled for completion by July 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Fentanyl 100 MCG/2 ML Vial 2ML, valued at $1,667.43. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This contract represents a child order under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Fentanyl 50 mcg/mL vials with a ceiling value of $1,220.24. The contract, awarded on November 13, 2025, represents a firm fixed-price delivery order with an ultimate completion date of November 14, 2025, and utilizes no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs the work at its corporate office location in...
- This delivery order awards AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, a contract valued at $1,658.68 for the supply of Fentanyl 100 micrograms/2 milliliters. The contract represents a firm fixed-price delivery order under a non-competitive set-aside, awarded by the Medical Supply Chain division of the Defense Logistics Agency on July 14, 2025, with an ultimate completion date of August 8, 2025. The place of performance is located in...
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,889.68 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the supply of 4565795691 - FENTANYL 250 MCG/5 ML VIAL 5ML, a critical pharmaceutical product, with a completion date of September 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,168.51, is for the supply of 4563927584 Fentanyl 100 MCG/2 ML vials. The contract is a Firm Fixed Price arrangement and has a completion date of March 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,013.60 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565832987 units of 100 mcg/2 fentanyl. The contract has a completion date of September 18, 2024 and is not set aside. This order is likely part of a larger Indefinite Delivery Contract (IDC) that the DLA has with Amerisourcebergen, valued up to $999,999,999, to provide a comprehensive range of medical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJS65Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Fentanyl 100 micrograms per 2 milliliters in 2 milliliter vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,774.26 and an ultimate completion date of September 3, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order supports the Defense Health Agency and military healthcare systems' pharmaceutical supply requirements. AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement, supplying an extensive range of medications and medical supplies across multiple therapeutic domains. The underlying IDC vehicle, designated SPE2DX, functions as a comprehensive global pharmaceutical support mechanism enabling the contractor to deliver brand-name and generic drugs, vaccines, and other medical commodities to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/2/25 |